Serum glucagon concentration and hyperinsulinaemia influence renal haemodynamics and urinary protein loss in normotensive patients with central obesity

被引:20
作者
Solerte, SB
Rondanelli, M
Giacchero, R
Stabile, M
Lovati, E
Cravello, L
Pontiggia, B
Vignati, G
Ferrari, E
Fioravanti, M
机构
[1] Univ Pavia, Sch Endocrinol & Metab, Dept Internal Med, I-27100 Pavia, Italy
[2] Univ Pavia, Chair Geriatr, I-27100 Pavia, Italy
[3] Osped Magenta, Lab Endocrine & Metab Dis, Magenta, Italy
关键词
obesity; body fat distribution; glucagon; insulin; NEFA; glomerular filtration rate; albuminuria; proteinuria; alpha; 1; microglobulin; arterial blood pressure; cardiovascular disease;
D O I
10.1038/sj.ijo.0801032
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES: Insulin-resistance syndrome and hyperinsulinaemia are linked with cardiovascular disease (CVD) in the obese population, In particular, cardiovascular risk is more frequent in central obesity and is associated with microalbuminuria (MA). MA and changes of glomerular permeability to proteins in obesity might be related with renal haemodynamic modifications (that is glomerular hyperfiltration). Since glucagon is physiologically involved in renal haemodynamic regulation, the purpose of this study was to examine whether changes of circulating glucagon levels might haemodynamically induce MA and proteinuria in patients with central obesity, SUBJECTS: Forty normotensive obese out-patients, 22 with central (CO group) and 18 with peripheral (PO group) body fat distribution and 11 healthy subjects. MEASUREMENTS: Serum insulin and glucagon concentrations (fasting and after oral glucose tolerance test (OGTT)) by radio immune assay (RIA); glomerular filtration rate (GFR, isotopic); total clearances and urinary excretion rates of albumin (AER), IgG (IgGER) and alpha 1 microglobulin (computerized immunonephelometry). RESULTS: GFR and insulin concentrations (fasting and during OGTT) were higher in the CO than the PO group. Fasting glucagon concentrations were increased, and not physiologically suppressed during OGTT in patients with CO (fasting, P < 0.05; OGTT 60 and 120 min, P < 0.001 vs PO group). Moreover, glucagon concentrations were significantly correlated with GFR in the CO group (fasting, r = 0.49, P < 0.05; 60 min after OGTT, r = 0.58, P < 0.01); whereas no correlations were found in the PO group. Higher AER (P < 0.001), IgGER (P < 0.001) and alpha 1 microglobulin (P < 0.05) urinary concentrations were found in patients with CO than in the PO group. CONCLUSIONS: The increase of serum glucagon concentrations may be associated with the enhancement of GFR in patients with central obesity. Glomerular hyperfiltration might influence the development of MA and of proteinuria by means of a haemodynamic mechanism so contributing to increase the risk of renal microvascular complications and of CVD in central obesity.
引用
收藏
页码:997 / 1003
页数:7
相关论文
共 45 条
  • [11] DEPRES JP, 1993, NUTRITION, V9, P452
  • [12] EFFECTS OF GLUCAGON ON RENAL FUNCTION IN MAN
    ELRICK, H
    HUFFMAN, ER
    HLAD, CJ
    WHIPPLE, N
    STAUB, A
    SMITH, AE
    YEARWOODDRAYTON, V
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1958, 18 (08) : 813 - 824
  • [13] INSULIN RESISTANCE IN ESSENTIAL-HYPERTENSION
    FERRANNINI, E
    BUZZIGOLI, G
    BONADONNA, R
    GIORICO, MA
    OLEGGINI, M
    GRAZIADEI, L
    PEDRINELLI, R
    BRANDI, L
    BEVILACQUA, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (06) : 350 - 357
  • [14] HYPERINSULINEMIA - THE KEY FEATURE OF A CARDIOVASCULAR AND METABOLIC SYNDROME
    FERRANNINI, E
    HAFFNER, SM
    MITCHELL, BD
    STERN, MP
    [J]. DIABETOLOGIA, 1991, 34 (06) : 416 - 422
  • [15] THE HEALTH OF THE NATION - RESPONSES - IMPORTANCE OF OBESITY
    GARROW, J
    [J]. BRITISH MEDICAL JOURNAL, 1991, 303 (6804) : 704 - 706
  • [16] EFFECTS OF PHYSIOLOGIC LEVELS OF GLUCAGON AND GROWTH-HORMONE ON HUMAN CARBOHYDRATE AND LIPID-METABOLISM - STUDIES INVOLVING ADMINISTRATION OF EXOGENOUS HORMONE DURING SUPPRESSION OF ENDOGENOUS HORMONE-SECRETION WITH SOMATOSTATIN
    GERICH, JE
    LORENZI, M
    BIER, DM
    TSALIKIAN, E
    SCHNEIDER, V
    KARAM, JH
    FORSHAM, PH
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1976, 57 (04) : 875 - 884
  • [17] MICROALBUMINURIA - POTENTIAL MARKER FOR INCREASED CARDIOVASCULAR RISK-FACTORS IN NONDIABETIC SUBJECTS
    HAFFNER, SM
    STERN, MP
    GRUBER, MKK
    HAZUDA, HP
    MITCHELL, BD
    PATTERSON, JK
    [J]. ARTERIOSCLEROSIS, 1990, 10 (05): : 727 - 731
  • [18] Response of insulin, glucagon, lactate, and nonesterified fatty acids to glucose in visceral obesity with and without NIDDM: Relationship to hypertension
    Iannello, S
    Campione, R
    Belfiore, F
    [J]. MOLECULAR GENETICS AND METABOLISM, 1998, 63 (03) : 214 - 223
  • [20] KISSEBAH AH, 1991, INT J OBESITY, V15, P109